Effect of combination of syndrome differentiation depending treatment and chemotherapy on prognostic factors in treating mid-late patients with non-small call lung cancer

Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban

Volumn 23, Issue 8, 2003, Pages 575-579

  Li, Liu ning ^a   Liu, Wei sheng ^a   Xu, Kai ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISCA PROTOCOL; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; HERBACEOUS AGENT; VP P PROTOCOL; VP-P PROTOCOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; PHYTOTHERAPY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUGS, CHINESE HERBAL; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHYTOTHERAPY; PROGNOSIS; REGRESSION ANALYSIS;

EID: 0142166197     PISSN: 10035370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)